Slowing Noted in Growth of Cancer Expenditures

This article originally appeared here.
Share this content:
Slowing Noted in Growth of Cancer Expenditures
Slowing Noted in Growth of Cancer Expenditures

THURSDAY, Jan. 21, 2016 (HealthDay News) -- From 1998 to 2012, cancer care expenditures increased at an annualized rate of 2.9 percent, although the growth slowed from 2007, according to a study published online Jan. 15 in Cancer.

James A. Lee, from the Altarum Institute in Ann Arbor, Mich., and colleagues examined trends in spending on cancer from 1998 through 2012. They used condition-specific distribution of expenditures from the Medical Expenditure Panel Survey together with data from the National Nursing Home Survey and other sources to allocate the Personal Health Care components of the National Health Expenditure Accounts.

The researchers found that from 1998 to 2012, cancer care expenditures increased at an annualized rate of 2.9 percent. During 2007 to 2009, the share of expenditures for hospital-based care dropped to a low of 48 percent. Between 2007 to 2009 and 2010 to 2012, there was a substantial decline in professional and clinical services' shares as the hospital share increased. For all payers, the treated prevalence decreased between the first and last study periods, with the exception of an 11.2 percent increase for private payers. Out-of-pocket expenditures decreased to 4.7 percent, while there was a slight increase in Medicare's share. There was an increase in medication expenditures, notably within mail order and retail settings.

"The previous rapid growth of cancer prevalence and expenditures has now slowed, most remarkably since the 2007 recession," the authors write.

The study was supported by the Pharmaceutical Research and Manufacturers of America.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »